We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is ...
A simple and reproducible test is still needed to identify in newly diagnosed stage A CLL patients, those patients with a higher risk of progressive disease. Toward this end, we prospectively ...
Outcomes of non-small cell lung cancer patients with adenocarcinoma histology compared with other histologies: SEER registry data 2004-2008. This is an ASCO Meeting Abstract from the 2012 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results